Related Experiment Video
Updated: Jul 16, 2026
10:09
Leprdb Mouse Model of Type 2 Diabetes: Pancreatic Islet Isolation and Live-cell 2-Photon Imaging Of Intact Islets
Published on: May 11, 2015
The virtual NOD mouse: applying predictive biosimulation to research in type 1 diabetes
Yanan Zheng1, Huub T C Kreuwel, Daniel L Young
1Entelos, Inc., 110 Marsh Drive, Foster City, CA 94404, USA.
Annals of the New York Academy of Sciences
|March 23, 2007
Summary
A new mathematical model of type 1 diabetes in virtual non-obese diabetic (NOD) mice simulates disease progression and therapeutic responses. Early intervention with IL-10 therapy is crucial for preventing diabetes in susceptible mice.
Area of Science:
- Immunology
- Computational Biology
- Endocrinology
Background:
- Type 1 diabetes involves autoimmune destruction of pancreatic beta cells.
- The non-obese diabetic (NOD) mouse is a key model for studying type 1 diabetes.
- Understanding disease heterogeneity is critical for effective therapeutic strategies.
Purpose of the Study:
- To develop a large-scale dynamic mathematical model of the female NOD mouse for type 1 diabetes research.
- To simulate disease progression, therapeutic responses, and heterogeneity in diabetes onset.
- To investigate the impact of disease heterogeneity on IL-10 therapy effectiveness.
Main Methods:
- Development of the Entelos Type 1 Diabetes PhysioLab platform, a mathematical model of the NOD mouse.
- Mathematical representation of immune system components and islet beta cell physiology.
- Simulation of virtual NOD mice with average and early diabetes onset, and assessment of IL-10 therapy responses.
Main Results:
- The model accurately reproduces experimentally observed dynamics of diabetes progression and IL-10 therapeutic responses.
- Disease heterogeneity significantly impacts the effectiveness of exogenous IL-10 therapy.
- Early-onset diabetes in NOD mice is linked to high levels of inflammation and beta cell destruction at treatment initiation.
Conclusions:
- The Type 1 Diabetes PhysioLab platform provides a valuable tool for studying type 1 diabetes pathogenesis and evaluating therapeutic strategies.
- Earlier administration of IL-10 therapy is essential for preventing diabetes onset in NOD mice, particularly those with early disease progression.
- The model highlights the importance of timing and disease stage in the efficacy of immunomodulatory treatments for type 1 diabetes.
Related Concept Videos
02:43Mouse Models of Cancer Study
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
02:43Mouse Models of Cancer Study
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...